Joel Greenblatt’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Joel Greenblatt's CYTK Position: Q3 2026 in Review
Joel Greenblatt sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 5,367 shares — an estimated $457K sold.
Joel Greenblatt first reported a position in CYTK in Q1 2017 and held it in 3 quarters. The position peaked at $641K in Q1 2017. 466 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Joel Greenblatt reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
- Joel Greenblatt sold 5,367 Cytokinetics shares in Q3 2026, an estimated $457K.
- Joel Greenblatt first reported a position in Cytokinetics in Q1 2017 and held it in 3 quarters.
- Joel Greenblatt's Cytokinetics position peaked at $641K in Q1 2017.
- 466 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.